Aims & Scope
Applied In Vitro Toxicology is a peer-reviewed journal providing the latest research on the application of alternative in vitro testing methods for predicting adverse effects in the pharmaceutical, chemical, and personal care industries. This Journal aims to address important issues facing the various chemical industries, including regulatory requirements; the reduction, refinement, and replacement of animal testing; new screening methods; evaluation of new cell and tissue models; and the most appropriate methods for assessing safety and satisfying regulatory demands. The Journal also delivers the latest views and opinions of developers of new models, end users of the models, academic laboratories that are inventing new tools, and regulatory agencies in the United States, Europe, Latin America, Australia and Asia.
Applied In Vitro Toxicology is the journal that scientists involved with hazard identification and risk assessment will read to understand how new and existing in vitro methods are applied, and the questions for which these models provide answers.
Applied In Vitro Toxicology coverage includes:
- Applied in vitro toxicology industry standards
- New technologies developed for applied in vitro toxicology
- Data acquisition, cleaning, distribution, and best practices
- Data protection, privacy, and policy
- Business interests from research to product
- The changing role of in vitro toxicology
- Visualization and design principles of applied in vitro toxicology infrastructures
- Physical interfaces and robotics
- Opportunities around applied in vitro toxicology
Applied In Vitro Toxicology is under the editorial leadership of Editor-in-Chief James M. McKim, PhD, DABT, CEO of IONTOX, Inc., and other leading researchers. View the entire editorial board.
Audience: Research and developmental scientists; pharmaceutical, veterinary, horticultural, and chemical researchers; toxicologists, product manufacturers, regulators, among others